Endocyte, Inc.(ECYT)- NASDAQ
  • Alexander Valtsev | Send Message 10 Jun

    Catalysts/Potential Catalysts for Endocyte ($ECYT) Investment: http://bit.ly/090616ECYT
      • Michael Blake Kuritz | Send Message 22 Jan

        $ECYT finally back to cash value. phase 3 is crap, phase 1 for lung cancer is gold. expect good results and fast track.
          • Scientist on Stocks | Send Message 21 Jan

            Endocyte: A Must Buy While Wall Street Goes Insane $ECYT http://seekingalpha.com/a/29zr8
              • Michael Blake Kuritz | Send Message 6 Jan

                At book value its looks like $ECYT can make a run again if they can just get their combo therapy to mkt 500 million from $MRK collab on line
                  • pat45 | Send Message 29 Sep 2015

                    $ECYT Selling for cash value $4.6 a share. This is when you know there is biotech rout . Any others selling for cash?
                      • pat45 | Send Message 22 Sep 2015

                        Benzinga reports $ECYT to present vintafolide data this weekend at cancer meeting
                          • InvestingInsights | Send Message 8 Sep 2015

                            $ECYT Cantor Reiterates Buy on Endocyte, Inc. Following Vintafolide Clinical Update http://bit.ly/1K54N6O
                              • pat45 | Send Message 8 Sep 2015

                                $ECYT ALOT of $6 calls bought. And presentations this week.
                                  • pat45 | Send Message 8 Sep 2015

                                    $ECYT p2 results 30%longer life for lung cancer. Has $4.70 cash per share and big insider buys. Also good drug pipeline
                                      • pat45 | Send Message 20 Jul 2015

                                        $ECYT Should have drug study results soon
                                        Reply (1)
                                        • matratra | Send Message 20 Jul 2015
                                          : let us know then please
                                          Company Description
                                          Endocyte, Inc. is a biopharmaceutical company, which develops targeted therapies for the treatment of cancer and inflammatory diseases. The company uses its proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted... More
                                          Sector: Healthcare
                                          Industry: Drug Manufacturers - Major
                                          Country: United States